标普生物科技LOF(161127)
动态评分： 6.09分
投资组合
| 报告日期 | 代码 | 名称 | 类型 | 金额(万元) | 占期初比 |
| 2018-12-31 | TSRO | TESARO Inc | 买入 | 166.9 | 2.12% |
| 2018-12-31 | HRTX | Heron Therapeutics Inc | 买入 | 165.08 | 2.09% |
| 2018-12-31 | ATRA | Atara Biotherapeutics Inc | 买入 | 162.25 | 2.06% |
| 2018-12-31 | ENTA | Enanta Pharmaceuticals Inc | 买入 | 161.84 | 2.05% |
| 2018-12-31 | RARE | Ultragenyx Pharmaceutical Inc | 买入 | 160.53 | 2.04% |
| 2018-12-31 | RGNX | REGENXBIO Inc | 买入 | 157.12 | 1.99% |
| 2018-12-31 | AGIO | Agios Pharmaceuticals Inc | 买入 | 155.29 | 1.97% |
| 2018-06-30 | ATRA | Atara Biotherapeutics Inc | 买入 | 98.35 | 1.25% |
| 2018-06-30 | ANAB | AnaptysBio Inc | 买入 | 89.37 | 1.13% |
| 2018-06-30 | PBYI | Puma Biotechnology Inc | 买入 | 79.66 | 1.01% |
| 2018-06-30 | GERN | 杰龙生物 | 买入 | 73.67 | 0.93% |
| 2018-06-30 | MDGL | Madrigal Pharmaceuticals Inc | 买入 | 73.25 | 0.93% |
| 2018-06-30 | SRNE | Sorrento Therapeutics Inc | 买入 | 73.05 | 0.93% |
| 2018-06-30 | BHVN | Biohaven Pharmaceutical Holding Co Ltd | 买入 | 69.31 | 0.88% |
| 2018-06-30 | ESPR | Esperion Therapeutics Inc | 买入 | 66.34 | 0.84% |
| 2018-06-30 | TSRO | TESARO Inc | 买入 | 66.42 | 0.84% |
| 2018-06-30 | PRTA | Prothena Corp plc | 买入 | 63.02 | 0.8% |
| 2018-06-30 | ADMS | Adamas Pharmaceuticals Inc | 买入 | 62 | 0.79% |
| 2018-06-30 | ACAD | 阿卡迪亚制药 | 买入 | 61.17 | 0.78% |
| 2018-06-30 | FMI | Foundation Medicine Inc | 买入 | 55.73 | 0.71% |
公告&资料
